Eric M Loeser is a prominent inventor based in Scotch Plains, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 8 patents. His work primarily focuses on developing innovative compounds that target specific diseases and disorders.

Latest Patents

One of his latest patents is titled "Forms and salts of a dihydropyrrolo[1,2c]imidazolyl aldosterone synthase or aromatase inhibitor." This invention relates to a phosphate salt or a nitrate salt of 4-(R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl-3-fluoro-benzonitrile, particularly in crystalline form. The salts and salt forms are designed for the prophylactic and/or therapeutic treatment of aldosterone synthase and/or aromatase mediated diseases or disorders. Another notable patent is "Salts of benzimidazolyl pyridyl ethers and formulations thereof." This patent provides salts of benzimidazolyl pyridyl ethers, specifically salts of {1-methyl-5-[2-(5-trifluoromethyl-1H-imidazol-2-yl)-pyridin-4-yloxy]-1H-benzoimidazol-2-yl}-(4-trifluoromethyl-phenyl)amine. It includes compositions and formulations that incorporate such salts and surfactants, along with methods for preparing these compositions.

Career Highlights

Throughout his career, Eric has worked with notable companies, including Novartis AG. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Eric has collaborated with several professionals in his field, including Prasad Koteswara Kapa and Paul Allen Sutton. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Eric M Loeser is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of several important patents. His innovative contributions continue to impact the field and improve therapeutic options for various diseases.

This text is generated by artificial intelligence and may not be accurate.